• Intel Hands Out Barf Bags At VR Presser
    One of virtual reality's biggest problems is its tendency to make people nauseous. So what was Intel to do when it hosted its 2017 CES press conference partly in VR? Apparently, make a tongue-in-cheek plan for the worst possible outcome. When attendees arrived, they were directed to chairs with a black table, an Oculus Rift, a laptop ... and a paper bag.
  • Sears Announces Additional Store Closings
    Sears announced a second wave of store closures on Wednesday, bringing the total number of closures scheduled for early 2017 to 150. The company will shut down 108 Kmart stores and 42 Sears stores by April, according to an internal document obtained by "Business Insider." That represents about 10% of Sears' store base.
  • More Retail Stores Likely To Close
    In a sign of how dramatically the landscape is changing when it comes to shopping, experts say don't expect any let-up in store closings in 2017 just because retailers just had the biggest growth in holiday sales in five years. A record amount of holiday spending went to online sellers. Much of the foot traffic in stores was driven by discounting.
  • United Diverts Flight After Passenger Goes On Racist Rant
    The passenger was onboard a San Francisco-bound United Airlines flight from Sydney, Australia, on New Year's Day when he began insulting two passengers of Indian or Pakistani descent who had been seated on either side of him, video posted to social media shows. A flight attendant made the call to divert the flight after the man started loudly cursing her out and making threats, passengers said.
  • Tom Brady Shuns Gatorade For This
    When most NFL players need to rehydrate during a game, they usually just grab a cup of water or a cup of Gatorade and guzzle it down. However, that's not what Tom Brady does because Tom Brady isn't going to pollute his body with that type of stuff. "I have this lemon drink with a ton of electrolytes in it," Brady said. "It doesn't have any sugar."
  • What To Expect From Samsung Galaxy Note 8
    The Samsung Galaxy Note 8 may include a voice assistant named Bixby. We've been hearing rumors about Bixby for quite some time now, and most recently we heard that the new digital assistant would likely be implemented into the Samsung Galaxy S8. Now, it looks like the Note 8 will get the same treatment. Bixby is said to be a male voice assistant.
  • Chrysler Unveils Electric Minivan At CES
    Chrysler revealed its Portal electric minivan at CES 2017. It measures much smaller than the current crop of minivans, but it is designed for a new generation, the Millennial, that by all accounts prefers an urban lifestyle. Chrysler's Millennial focus with the Portal meant a design that started on the inside, with the idea of creating a comfortable and open space.
  • Ford Cancels Plans For Mexican Plant
    Ford is investing $700 million to expand its Flat Rock, Mich., assembly plant and hire 700 new hourly workers to build self-driving and electric vehicles along with the Mustang and Lincoln Continental already produced at the site. The automaker also said it is canceling plans for a new $1.6 billion plant in San Luis Potosi, Mexico, but confirmed that the next-generation of its Focus compact will be produced at its Hermosillo, Mexico, factory.
  • Volkswagen Acquires PayByPhone Mobile Parking Service
    Volkswagen AG's financial services arm has acquired Vancouver-based mobile parking payment company PayByPhone in a race to get a foothold in the future transport economy. PayByPhone processes more than $250 million in payments each year, allows its users to securely pay for certain parking spaces with their phones and be alerted when their time expires.
  • Sanofi Sues Novo Over Marketing Claims
    Sanofi and Novo Nordisk are battling for market share in an increasingly competitive insulin field. France's Sanofi has sued Novo over the Danish drugmaker's marketing materials for Tresiba, alleging that they falsely claimed Sanofi's competing products-blockbuster Lantus and follow-up Toujeo-won't be available to many U.S. patients down the line.
« Previous EntriesNext Entries »